Cargando…

Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma

PURPOSE: The treatment outcomes and genomic profiles of diffuse midline glioma (DMG) in adult patients are rarely characterized. We performed a retrospective study to evaluate the clinicogenomic profiles of adult patients with brain DMG. MATERIALS AND METHODS: Patients aged ≥ 18 years diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Changhee, Kim, Tae Min, Bae, Jeong Mo, Yun, Hongseok, Kim, Jin Wook, Choi, Seung Hong, Lee, Soon-Tae, Lee, Joo Ho, Park, Sung-Hye, Park, Chul-Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053865/ https://www.ncbi.nlm.nih.gov/pubmed/33171023 http://dx.doi.org/10.4143/crt.2020.694

Ejemplares similares

MYB/MYBL1::QKI fusion-positive diffuse glioma
por: Suh, Ye Yoon, et al.
Publicado: (2023)

The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1
por: Yoon, Hong In, et al.
Publicado: (2021)

A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma
por: Kim, Sung Kwon, et al.
Publicado: (2020)

Deep learning based on dynamic susceptibility contrast MR imaging for prediction of local progression in adult-type diffuse glioma (grade 4)
por: Heo, Donggeon, et al.
Publicado: (2023)

The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
por: Lee, Yujin, et al.
Publicado: (2017)

Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas
por: Park, Chul-Kee, et al.
Publicado: (2015)

Long-term survivors of glioblastoma are a unique group of patients lacking universal characteristic features
por: Park, Chul-Kee, et al.
Publicado: (2019)

The telomere maintenance mechanism spectrum and its dynamics in gliomas
por: Kim, Sojin, et al.
Publicado: (2022)

The prognostic significance of p16 expression pattern in diffuse gliomas
por: Park, Jin Woo, et al.
Publicado: (2021)

Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis
por: Lee, Kwanghoon, et al.
Publicado: (2023)

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
por: Di Ruscio, Valentina, et al.
Publicado: (2022)

Immunotherapy approaches for the treatment of diffuse midline gliomas
por: Bernstock, Joshua D., et al.
Publicado: (2022)

Interdisciplinary care of children with diffuse midline glioma
por: Coleman, Christina, et al.
Publicado: (2022)

The promise of metabolic imaging in diffuse midline glioma
por: Lovibond, Samantha, et al.
Publicado: (2023)

Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas
por: Hong, Eun Kyoung, et al.
Publicado: (2021)

Clinical Features and Prognosis of Diffuse Midline Glioma: A Series of 24 Cases
por: Jang, Sun Woo, et al.
Publicado: (2022)

Radiological assessment schedule for 1p/19q-codeleted gliomas during the surveillance period using parametric modeling
por: Kang, Ho, et al.
Publicado: (2021)

CNSC-01. GABAERGIC NEURON-TO-GLIOMA SYNAPSES IN DIFFUSE MIDLINE GLIOMAS
por: Barron, Tara, et al.
Publicado: (2023)

Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
por: Hayden, Elisha, et al.
Publicado: (2021)

DIPG-44. DIFFUSE MIDLINE GLIOMA WITH EXTRACRANIAL METASTASIS
por: Larsen, Alexandra Giantini, et al.
Publicado: (2023)

Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging
por: Lee, Eun Kyoung, et al.
Publicado: (2015)

Gliomas: Application of Cumulative Histogram Analysis of Normalized Cerebral Blood Volume on 3 T MRI to Tumor Grading
por: Kim, Hyungjin, et al.
Publicado: (2013)

Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high-grade glioma patients
por: Kim, Tae-Hyung, et al.
Publicado: (2016)

Validation of MRI-Based Models to Predict MGMT Promoter Methylation in Gliomas: BraTS 2021 Radiogenomics Challenge
por: Kim, Byung-Hoon, et al.
Publicado: (2022)

Radio-Resistance and DNA Repair in Pediatric Diffuse Midline Gliomas
por: Pedersen, Henriette, et al.
Publicado: (2020)

Diffuse midline glioma in the spinal cord with rapid respiratory deterioration
por: Kamidani, Ryo, et al.
Publicado: (2020)

DIPG-39. New preclinical models for Diffuse Midline Glioma
por: Klenner, Marbod, et al.
Publicado: (2022)

DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)
por: Holliday, Holly, et al.
Publicado: (2022)

A homogeneous treatment for non-DIPG diffuse midline glioma
por: Schiavello, Elisabetta, et al.
Publicado: (2022)

Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma
por: Miguel Llordes, Gloria, et al.
Publicado: (2023)

Diffuse midline glioma treated with epigenetic agent-based immunotherapy
por: Jing, Linkai, et al.
Publicado: (2023)

Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea
por: Bae, So Hyun, et al.
Publicado: (2014)

White Matter Change Revealed by Diffusion Tensor Imaging in Gliomas
por: Won, Young Il, et al.
Publicado: (2016)

Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging
por: Kim, Jae Hyun, et al.
Publicado: (2014)

Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing
por: Yim, Jeemin, et al.
Publicado: (2022)

Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma
por: Park, Chul-Kee, et al.
Publicado: (2014)

MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction
por: Kim, Bo Ram, et al.
Publicado: (2016)

Xeroderma pigmentosum presenting as a diffuse midline glioma in a patient with skin of color
por: Plante, John, et al.
Publicado: (2021)

Mechanism for enhanced 5-aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomas
por: Kim, Ja Eun, et al.
Publicado: (2015)

Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma
por: Price, Gabrielle, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fp2p98seb907eelacoh105k6j7